International Journal of Pharmaceutical Sciences and Drug Analysis
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal

P-ISSN: 2788-9246, E-ISSN: 2788-9254
Printed Journal   |   Refereed Journal   |   Peer Reviewed Journal
Peer Reviewed Journal

2025, Vol. 5, Issue 1, Part A

Guillain-barre syndrome presenting with atypical neurological manifestations in L3 vertebral lesion: A case report


Author(s): Vignesh M, Lashika LK, Rakshana KS and Priscilla Mary J

Abstract: Guillain-Barre Syndrome (GBS) and other autoimmune illnesses are known to cause symmetrical paralysis and areflexia. An 80-year-old woman with atypical GBS is reported in a case report as experiencing right leg pain, dysarthria, trouble standing, and an L3 cord lesion on MRI. Her neurological conditions appear to have been exacerbated by her medical history, which includes diabetes and hypertension. After an electrical test revealed demyelination and a cerebral fluid evaluation revealed albuminocytologic dissociation, this diagnosis was made. Similar to the aforementioned scenario, GBS necessitates a thorough differential diagnosis in order to distinguish it from structural illnesses like radiculopathy or viral spondylitis. The importance of supportive treatment is shown by the favourable clinical outcomes obtained following complete patient care, which includes physical therapy, pain management, and immunotherapy with IVIg. This example illustrates the clinical variability of GBS and the need for heightened suspicion in atypical presentations. Better patient outcomes in complicated nervous system illnesses depend on early diagnosis and a multidisciplinary approach.

DOI: 10.22271/27889246.2025.v5.i1a.105

Pages: 35-38 | Views: 107 | Downloads: 48

Download Full Article: Click Here

International Journal of Pharmaceutical Sciences and Drug Analysis
How to cite this article:
Vignesh M, Lashika LK, Rakshana KS, Priscilla Mary J. Guillain-barre syndrome presenting with atypical neurological manifestations in L3 vertebral lesion: A case report. Int J Pharm Sci Drug Anal 2025;5(1):35-38. DOI: 10.22271/27889246.2025.v5.i1a.105
International Journal of Pharmaceutical Sciences and Drug Analysis
Call for book chapter